Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-alpha.

Abstract:

:The antitumor activity of combination therapy with recombinant tumor necrosis-alpha (rhTNF-alpha) and recombinant interleukin-2 (rhIL-2) was assessed against established immunogenic (MCA-106) and nonimmunogenic (MCA-102) sarcomas at both s.c. and visceral (hepatic) sites. C57BL/6 (B6) mice were treated with a single i.v. dose of rhTNF-alpha (2, 4, 6, or 8 micrograms) followed by rhIL-2 (25,000 U) i.p. thrice daily for 5 consecutive days. Synergistic effects as measured by regression of tumor, prolongation of survival, and improved cure rates were found using the combination of rhTNF-alpha plus rhIL-2 compared to rhTNF-alpha alone or rhIL-2 alone in the treatment of the immunogenic sarcoma MCA-106. No significant antitumor effects were observed against the nonimmunogenic MCA-102 sarcoma. These findings were similar for both s.c. and large single hepatic tumor models. The effect of the timing of rhIL-2 injections in relation to rhTNF-alpha administration (concurrent, 2, 4, or 6 days post single rhTNF-alpha dose) was also evaluated. Substantial tumor regression and increased survival times were seen in mice with s.c. tumors when rhIL-2 therapy was delayed as much as 48 h after rhTNF-alpha administration. No antitumor response was noted with the combination compared to rhTNF-alpha alone when rhIL-2 was delayed for greater than 4 days. No increase in lethal toxicity during treatment course of the combination of rhTNF-alpha and rhIL-2 was noted at any schedule compared to single agent rhTNF-alpha therapy. A possible role of rhTNF-alpha in regulation of IL-2-dependent antitumor activity in vivo is discussed.

journal_name

Cancer Res

journal_title

Cancer research

authors

McIntosh JK,Mulé JJ,Merino MJ,Rosenberg SA

subject

Has Abstract

pub_date

1988-07-15 00:00:00

pages

4011-7

issue

14

eissn

0008-5472

issn

1538-7445

journal_volume

48

pub_type

杂志文章
  • Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation.

    abstract::Retinoic acid receptors and retinoid X receptors form heterodimers, bind to retinoic acid response elements, and transactivate the transcription of retinoid-responsive genes. Two synthetic retinoids [4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid (TTAB) and 6-(5,6,7,8-tetrahydro-5,5,8,8-tetrameth...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lotan R,Dawson MI,Zou CC,Jong L,Lotan D,Zou CP

    更新日期:1995-01-15 00:00:00

  • Effect of hepatocarcinogens on the adenine purine nucleotide cycle during the initiation phase of carcinogenesis.

    abstract::Activities of the adenine purine nucleotide cycle enzymes, i.e., adenylosuccinate (SAMP) synthetase, SAMP lyase, and adenosine 5'-monophosphate deaminse, were determined in hepatic tissue of rats fed and/or given injections of 3'-methyl-4-dimethylaminoazobenzene, 4'-methyl-4-dimethylaminoazobenzene, thioacetamide, eth...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Smith LD,Emerson RL,Nixon LK

    更新日期:1979-06-01 00:00:00

  • Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer.

    abstract::Hypoxic conditions exist within pancreatic adenocarcinoma, yet pancreatic cancer cells survive and replicate within this environment. To understand the mechanisms involved in pancreatic cancer adaptation to hypoxia, we analyzed expression of a regulator of hypoxia-induced cell death, Bcl-2/adenovirus E1B 19 kDa intera...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-0089

    authors: Okami J,Simeone DM,Logsdon CD

    更新日期:2004-08-01 00:00:00

  • Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regression.

    abstract::LIGHT, a ligand for the lymphotoxin-beta receptor, establishes lymphoid-like tissues inside tumor sites and recruits naïve T cells into the tumor. However, whether these infiltrating T cells are specific for tumor antigens is not known. We hypothesized that therapy with LIGHT can expand functional tumor-specific CD8(+...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3773

    authors: Kanodia S,Da Silva DM,Karamanukyan T,Bogaert L,Fu YX,Kast WM

    更新日期:2010-05-15 00:00:00

  • Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.

    abstract::Cell-mediated cytotoxicity against syngeneic MC104 fibrosarcoma cells was detected in C57BL/6N mice 7 days after tumor inoculation in the hind foot. This cytotoxicity was undetectable by Day 14 in the Winn test using spleen and draining popliteal lymph node (DPLN) cells. Similar results were obtained with the 51Cr rel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kawase I,Uemiya M,Yoshimoto T,Ogura T,Hirao F,Yamamura Y

    更新日期:1981-02-01 00:00:00

  • Morphological and functional differentiation of Kirsten murine sarcoma virus-transformed rat adrenocortical cell lines.

    abstract::This study was undertaken to examine relationships of the phenotype of malignant cells to target cell properties and to events early in the transformation process. Eighteen transformed lines were obtained by Kirsten murine sarcoma virus infection of cells from adrenal glands of rats ages 4 to 30 weeks, at first or sec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Auersperg N,Wan MW,Sanderson RA,Wong KS,Mauldin D

    更新日期:1981-05-01 00:00:00

  • Tumor necrosis factor alpha polymorphism correlates with deleterious effects of ultraviolet B light on cutaneous immunity.

    abstract::Intradermally injected tumor necrosis factor alpha (TNF-alpha) mimics the effects of UV B light (UVB) radiation and neutralizing anti-TNF-alpha antibodies abolish the deleterious effects of UVB on induction of contact hypersensitivity suggesting that TNF-alpha is the major mediator of UVB effects on cutaneous immunity...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Vincek V,Kurimoto I,Medema JP,Prieto E,Streilein JW

    更新日期:1993-02-15 00:00:00

  • Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression.

    abstract::In a previous study, we found that the small-molecule epidermal growth factor receptor (EGFR) inhibitor gefitinib (ZD1839, Iressa) blocked cell proliferation at biologically relevant concentrations in approximately one third (6 of 17) of human bladder cancer cell lines examined. Here, we studied the effects of gefitin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1224

    authors: Shrader M,Pino MS,Lashinger L,Bar-Eli M,Adam L,Dinney CP,McConkey DJ

    更新日期:2007-02-15 00:00:00

  • Involvement of estrogen receptor beta in ovarian carcinogenesis.

    abstract::Knockout and expression studies suggest that estrogen receptor beta (ERbeta) plays a prominent role in ovarian function and pathology. Moreover, ovarian cancers are characterized by high morbidity and low responsiveness to anti-estrogens. Here we demonstrate, using quantitative PCR to measure ERalpha and ERbeta levels...

    journal_title:Cancer research

    pub_type: 杂志文章,收录出版

    doi:10.1158/0008-5472.CAN-04-0552

    authors: Bardin A,Hoffmann P,Boulle N,Katsaros D,Vignon F,Pujol P,Lazennec G

    更新日期:2004-08-15 00:00:00

  • The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.

    abstract::Our objectives were to test whether polymorphic variation in the (CAG)n repeat of the androgen receptor (AR) gene affects penetrance of germ-line BRCA mutations for ovarian cancer or age of diagnosis for ovarian cancer. Using a case-series study design, 179 consecutive Ashkenazi Jewish ovarian cancer patients were gen...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Levine DA,Boyd J

    更新日期:2001-02-01 00:00:00

  • Activation of EDTA-resistant gelatinases in malignant human tumors.

    abstract::Among the many proteases associated with human cancer, seprase or fibroblast activation protein alpha, a type II transmembrane glycoprotein, has two types of EDTA-resistant protease activities: dipeptidyl peptidase and a 170-kDa gelatinase activity. To test if activation of gelatinases associated with seprase could be...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1499

    authors: Chen D,Kennedy A,Wang JY,Zeng W,Zhao Q,Pearl M,Zhang M,Suo Z,Nesland JM,Qiao Y,Ng AK,Hirashima N,Yamane T,Mori Y,Mitsumata M,Ghersi G,Chen WT

    更新日期:2006-10-15 00:00:00

  • Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines.

    abstract::Transformation with ras oncogenes results in increased radiation sur vival in many but not all cells. In addition, prenyltransferase inhibitors which inhibit ras proteins by blocking posttranslational modification radiosensitize cells with oncogenic ras. These findings suggest that oncogenic ras contributes to intrins...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bernhard EJ,Stanbridge EJ,Gupta S,Gupta AK,Soto D,Bakanauskas VJ,Cerniglia GJ,Muschel RJ,McKenna WG

    更新日期:2000-12-01 00:00:00

  • Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.

    abstract::We have examined the properties of the estrogen receptor and progesterone receptor in MDA-MB-134 human breast cells and have evaluated the effects of estrogen on cell proliferation and progesterone receptor levels in these cells as indices of hormonal sensitivity. These cells contain high levels of estrogen receptor (...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reiner GC,Katzenellenbogen BS

    更新日期:1986-03-01 00:00:00

  • Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines.

    abstract::Previously, we identified an amplified gene in a stomach cancer cell line, KATO-III, and designated it K-sam. This gene was later found to be identical with a gene for a receptor tyrosine kinase, bek/FGFR2. One of the characteristics of the K-sam gene is structural diversity of its transcripts; K-sam complementary DNA...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ishii H,Hattori Y,Itoh H,Kishi T,Yoshida T,Sakamoto H,Oh H,Yoshida S,Sugimura T,Terada M

    更新日期:1994-01-15 00:00:00

  • Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane; ADR-529] and ICRF-159 (Razoxane).

    abstract::Certain bis(2,6-dioxopiperazine) derivatives, which include ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl]propane; ADR-529) and its racemic compound ICRF 159 (Razoxane), have been investigated as antineoplastic agents. In addition, ICRF-187 is currently under intense study as an agent to ameliorate the cardiac toxic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gorbsky GJ

    更新日期:1994-02-15 00:00:00

  • Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.

    abstract::Repurposing "old" drugs can facilitate rapid clinical translation but necessitates novel mechanistic insight. Warfarin, a vitamin K "antagonist" used clinically for the prevention of thrombosis for more than 50 years, has been shown to have anticancer effects. We hypothesized that the molecular mechanism underlying it...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-2887-T

    authors: Kirane A,Ludwig KF,Sorrelle N,Haaland G,Sandal T,Ranaweera R,Toombs JE,Wang M,Dineen SP,Micklem D,Dellinger MT,Lorens JB,Brekken RA

    更新日期:2015-09-15 00:00:00

  • Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells.

    abstract::Histone demethylase LSD1 (also known as KDM1 and AOF2) is active in various cancer cells, but its biological significance in human carcinogenesis is unexplored. In this study, we explored hypothesized interactions between LSD1 and MYPT1, a known regulator of RB1 phosphorylation. We found that MYPT1 was methylated in v...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2446

    authors: Cho HS,Suzuki T,Dohmae N,Hayami S,Unoki M,Yoshimatsu M,Toyokawa G,Takawa M,Chen T,Kurash JK,Field HI,Ponder BA,Nakamura Y,Hamamoto R

    更新日期:2011-02-01 00:00:00

  • LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer.

    abstract::Leucine-rich repeat-containing 3B (LRRC3B) is an evolutionarily highly conserved leucine-rich repeat-containing protein, but its biological significance is unknown. Using restriction landmark genomic scanning and pyrosequencing, we found that the promoter region of LRRC3B was aberrantly methylated in gastric cancer. G...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0667

    authors: Kim M,Kim JH,Jang HR,Kim HM,Lee CW,Noh SM,Song KS,Cho JS,Jeong HY,Hahn Y,Yeom YI,Yoo HS,Kim YS

    更新日期:2008-09-01 00:00:00

  • Identification of aldophosphamide as a metabolite of cyclophosphamide in vitro and in vivo in humans.

    abstract::Aldophosphamide (NSC 254), a putative key metabolite of cyclophosphamide, has now been isolated as a cyanohydrin derivative from an incubation mixture of cyclophosphamide with mouse liver microsomes in vitro and from the plasma of a cyclophosphamide-treated patient. The cyanohydrin has been shown to be identical with ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fenselau C,Kan MN,Rao SS,Myles A,Friedman OM,Colvin M

    更新日期:1977-08-01 00:00:00

  • Comparison of virus reactivation, DNA base damage, and cell cycle effects in autologous human melanoma cells resistant to methylating agents.

    abstract::A human melanoma cell line (MM253c1-3D) having an induced stable resistance to the methylating agents 5-(3'-methyl-1-triazeno)imidazole-4-carboxamide, methylnitrosourea, and N-methyl-N'-nitro-N-nitrosoguanidine gave more efficient replication of 5-(3'-methyl-1-triazeno)imidazole-4-carboxamide-treated adenovirus 5 than...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hayward IP,Parsons PG

    更新日期:1984-01-01 00:00:00

  • Semiautomated assessment of loss of heterozygosity and replication error in tumors.

    abstract::Loss of heterozygosity (LOH) and replication error (RER) are important phenomena in tumor development, with diagnostic and prognostic relevance. Therefore, screening for LOH and RER is a desirable first step in the molecular analysis of tumors. We used semiautomated procedures based on multicolor fluorescently labeled...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Canzian F,Salovaara R,Hemminki A,Kristo P,Chadwick RB,Aaltonen LA,de la Chapelle A

    更新日期:1996-07-15 00:00:00

  • AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner.

    abstract::More than 35 different partner genes with the mixed lineage leukemia (MLL) gene have been cloned from leukemia cells with translocations involving chromosome 11 band q23. In this study, we report on a novel fusion partner of the MLL gene, AF4p12, which we have identified as the human homologue to the furry gene of Dro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1325

    authors: Hayette S,Cornillet-Lefebvre P,Tigaud I,Struski S,Forissier S,Berchet A,Doll D,Gillot L,Brahim W,Delabesse E,Magaud JP,Rimokh R

    更新日期:2005-08-01 00:00:00

  • Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.

    abstract::It has been shown in previous studies that a variety of estrogen receptor (ER) beta mRNA transcripts are expressed in human breast cancer cell lines and tumors. To complement the RNA expression studies, we have developed ER-beta-specific antibodies to characterize ER-beta protein expression in breast cancer cell lines...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fuqua SA,Schiff R,Parra I,Friedrichs WE,Su JL,McKee DD,Slentz-Kesler K,Moore LB,Willson TM,Moore JT

    更新日期:1999-11-01 00:00:00

  • Inactivation of 1,3-, 1,6-, and 1,8-dinitropyrene by cytochrome P-450 enzymes in human and rat liver microsomes.

    abstract::NADPH-fortified human liver microsomes were examined with regard to ability to detoxicate several chemicals that do not require enzymatic oxidation to elicit a genotoxic response in a Salmonella typhimurium TA1535/pSK1002 system where umu response is used as an indicator of DNA damage. Microsomes did not affect the re...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shimada T,Guengerich FP

    更新日期:1990-04-01 00:00:00

  • Antimetastatic activity of a preventive cancer vaccine.

    abstract::The development of prophylactic cancer vaccines that protect healthy hosts from tumor development leaves open the question whether such vaccines are also effective against established tumors and metastases. We tested the therapeutic activity of a proven prophylactic anti-HER-2/neu vaccine against successive stages of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-2499

    authors: Nanni P,Nicoletti G,Palladini A,Croci S,Murgo A,Antognoli A,Landuzzi L,Fabbi M,Ferrini S,Musiani P,Iezzi M,De Giovanni C,Lollini PL

    更新日期:2007-11-15 00:00:00

  • Establishment and characterization of four new human non-small cell lung cancer cell lines.

    abstract::Four new human non-small cell lung cancer cell lines have been established in vitro. These cell lines have been characterized by (a) growth of a tumor in nude mice with histopathology similar to that of the primary, (b) isoenzyme patterns phenotypically human and distinct from each other, (c) distinguishing karyotypic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Loh PM,Clamon GH,Robinson RA,White ML,Hukku B,Rossi NP,Peterson WD

    更新日期:1984-08-01 00:00:00

  • N,N-Dimethylformamide-induced morphological differentiation and reduction of tumorigenicity in cultured mouse rhabdomyosarcoma cells.

    abstract::N,N-Dimethylformamide treatment of cell cultures established from a transplantable murine rhabdomyosarcoma-induced morphological differentiation and a marked reduction in the tumorigenicity of the sarcoma cells. Fourteen of 17 CE/J mice receiving injections of inducer-treated cells did not develop tumors after 6 month...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dexter DL

    更新日期:1977-09-01 00:00:00

  • Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses.

    abstract::Anticancer vaccine strategies can now target intracellular antigens that are involved in the process of malignant transformation, such as oncogene products or mutated tumor suppressor genes. Fragments of these antigens, generally 8-10 amino acids in length and complexed with MHC class I molecules, can be recognized by...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: McCabe BJ,Irvine KR,Nishimura MI,Yang JC,Spiess PJ,Shulman EP,Rosenberg SA,Restifo NP

    更新日期:1995-04-15 00:00:00

  • Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase.

    abstract::alpha-Interferon (IFN alpha) potentiates the cytotoxicity of 5-fluorouracil (FUra) in vitro, and the combination has clinical efficacy in advanced colorectal cancer. We have reported previously an IFN alpha-mediated elevation in cellular FdUMP levels accompanied by the stimulation of thymidine phosphorylase (TP) activ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Schwartz EL,Baptiste N,O'Connor CJ,Wadler S,Otter BA

    更新日期:1994-03-15 00:00:00

  • An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.

    abstract::Osteosarcoma is the most common malignant bone tumor in children. Osteosarcoma patients who respond poorly to chemotherapy are at a higher risk of relapse and adverse outcome. Therefore, it was the aim of this study to identify prognostic factors at the time of diagnosis to characterize the genes predictive of poor su...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2463

    authors: Mintz MB,Sowers R,Brown KM,Hilmer SC,Mazza B,Huvos AG,Meyers PA,Lafleur B,McDonough WS,Henry MM,Ramsey KE,Antonescu CR,Chen W,Healey JH,Daluski A,Berens ME,Macdonald TJ,Gorlick R,Stephan DA

    更新日期:2005-03-01 00:00:00